Cellebrite DI Ltd. Deferred Federal Income Tax Expense (Benefit)
Cellebrite DI Ltd. (CLBT) reported Deferred Federal Income Tax Expense (Benefit) of -$1.56 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-03
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$1.56M 20-F · filed 2026-03-03 |
| 2024-12-31 | -$3.16M 20-F · filed 2026-03-03 |
| 2023-12-31 | $1.60M 20-F · filed 2026-03-03 |
| 2022-12-31 | -$85.00K 20-F · filed 2025-03-18 |
| 2021-12-31 | -$10.00K 20-F · filed 2024-03-21 |
| 2020-12-31 | -$3.73M 20-F · filed 2023-04-27 |
| 2019-12-31 | -$1.90M 20-F · filed 2022-03-29 |